September 21, 2018
Dr. Takumi Kishimoto Takumi Kishimoto, director of the Japan Organization of Occupational Health and Safety’s asbestos-related diseases research center, welcomed the expanded indication for malignant pleural mesothelioma granted to the PD-1 inhibitor Opdivo (nivolumab), which became a new treatment option...read more